DiaMedica Therapeutics Inc. (DMAC): who owns it and who trades it
As of Nov 16, 2026, DMAC insiders reported 7 purchases worth $7.6M in the last 12 months. The largest buyer was Ab Trill (10% owner), with $7.6M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling DiaMedica Therapeutics
From the latest filingsOverall: more buying than selling. Insiders mostly bought. Funds and famous investors were close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns DMAC
89 funds and institutions reported DMAC shares worth $88.5M at the end of Q2 2026, about 23% of the company. The largest holder is Cooperman Leon G with 6.4%.
Funds and institutions (13F) 23%Everyone else 77%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Cooperman Leon G | 3.45M | 6.40% | $24.3M | +71% |
| BlackRock, Inc. | 2.25M | 4.18% | $15.9M | +21% |
| Geode Capital Management, LLC | 894,115 | 1.66% | $6.3M | +15% |
| Millennium Management LLC | 845,309 | 1.57% | $6M | -10% |
| State Street Corp | 646,743 | 1.20% | $4.6M | +0% |
| Bleichroeder LP | 382,317 | 0.71% | $2.7M | No change |
| Vanguard Capital Management LLC | 355,523 | 0.66% | $2.5M | +7% |
| Osaic Holdings, Inc. | 338,107 | 0.63% | $2.4M | +6% |
| Northern Trust Corp | 327,518 | 0.61% | $2.3M | -3% |
| Vanguard Portfolio Management LLC | 251,671 | 0.47% | $1.8M | +24% |
| LPL Financial LLC | 233,500 | 0.43% | $1.6M | +3% |
| Vanguard Fiduciary Trust Co | 207,438 | 0.38% | $1.5M | +11% |
| Goldman Sachs Group Inc | 168,066 | 0.31% | $1.2M | +183% |
| Citadel Advisors LLC | 145,870 | 0.27% | $1M | +0% |
| Squarepoint Ops LLC | 145,247 | 0.27% | $1M | New |
| Bank of New York Mellon Corp | 117,820 | 0.22% | $829K | +6% |
| Members Wealth LLC | 101,382 | 0.19% | $714K | No change |
| Charles Schwab Investment Management Inc | 96,691 | 0.18% | $681K | +9% |
| Sixth Street Partners Management Company, L.P. | 96,691 | 0.18% | $681K | New |
| Cobalt Capital Management, Inc. | 90,000 | 0.17% | $634K | New |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, DMAC insiders reported $7.6M of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | Ab Trill +1 | 10% owner | Purchase | 73,099 | $8.57 | $626K | Form 4 |
| Nov 24, 2025 | Ab Trill +1 | 10% owner | Purchase | 40,253 | $7.89 | $318K | Form 4 |
| Nov 21, 2025 | Ab Trill +1 | 10% owner | Purchase | 208,872 | $7.41 | $1.5M | Form 4 |
| Nov 20, 2025 | Ab Trill +1 | 10% owner | Purchase | 128,426 | $7.41 | $952K | Form 4 |
| Nov 19, 2025 | Ab Trill +1 | 10% owner | Purchase | 240,352 | $7.21 | $1.7M | Form 4 |
| Nov 18, 2025 | Ab Trill +1 | 10% owner | Purchase | 182,882 | $6.75 | $1.2M | Form 4 |
| Nov 17, 2025 | Ab Trill +1 | 10% owner | Purchase | 187,393 | $6.52 | $1.2M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Ab Trill | 10% owner | $7.6M | – | Nov 25, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
DMAC short interest
Moderate short interest. 9.3% of DMAC shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went up 4%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 5.02M DMAC shares were sold short, 9.3% of the shares outstanding, down 4.3% from the report before. At the average daily volume of 202,577 shares, buying them all back would take about 24.8 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 5.02M | 9.31% | -4% | 202,577 | 24.8 |
| Oct 15, 2026 | 5.24M | 9.72% | -6% | 242,863 | 21.6 |
| Sep 30, 2026 | 5.58M | 10.35% | +2% | 239,649 | 23.3 |
| Sep 15, 2026 | 5.49M | 10.17% | +2% | 149,628 | 36.7 |
| Aug 31, 2026 | 5.39M | 10.00% | +1% | 114,369 | 47.2 |
| Aug 14, 2026 | 5.36M | 9.93% | +3% | 141,508 | 37.9 |
| Jul 31, 2026 | 5.20M | 9.66% | +2% | 189,914 | 27.4 |
| Jul 15, 2026 | 5.11M | 9.49% | -2% | 241,120 | 21.2 |
| Jun 30, 2026 | 5.21M | 9.66% | +7% | 293,665 | 17.7 |
| Jun 15, 2026 | 4.86M | 9.02% | -0% | 172,215 | 28.2 |
| May 29, 2026 | 4.87M | 9.04% | +1% | 160,038 | 30.4 |
| May 15, 2026 | 4.84M | 8.99% | -1% | 176,979 | 27.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
DiaMedica Therapeutics company events
DiaMedica Therapeutics filed 6 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 10, 2026.
- Aug 10, 2026ResultsReleased financial results. Filing
- May 21, 2026VoteReported shareholder vote results. Filing
- May 6, 2026ResultsReleased financial results. Filing
- Mar 31, 2026ResultsReleased financial results. Filing
- Jan 5, 2026AnnouncementOn December 19, 2025 DiaMedica Therapeutics Inc. Sold 1,501,000 common shares to a healthcare institution fund at a purchase price of $8.10 per share in a block transaction under its at-the-market offering program. Filing
- Dec 18, 2025AnnouncementAs previously announced, DiaMedica requested and completed an in-person pre-IND meeting with the FDA for a planned study evaluating DM199 in pre-eclampsia. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
DiaMedica Therapeutics financials
Famous investors that hold DMAC
2 of the 50 well-known investors we track reported holding DMAC in their latest 13F filing. The largest position is Israel Englander's, worth $6.9M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 831,081 | $6.9M | 0.0% | -2% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 184,950 | $1.5M | 0.0% | +27% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about DiaMedica Therapeutics Inc. (DMAC) stock
Who owns the most DMAC stock?
The largest reported owner of DiaMedica Therapeutics Inc. (DMAC) is Cooperman Leon G, with 6.4% of the company. In total, 89 funds and institutions reported holding DMAC at the end of Q2 2026, together about 23% of the shares. See the largest owners.
Are DMAC insiders buying or selling?
In the last 12 months, DMAC insiders reported 7 open-market purchases worth $7.6M and no sales. The latest trade was on Nov 25, 2025. See every trade.
What is the short interest in DMAC?
As of Oct 30, 2026, 5.02M DMAC shares were sold short, 9.3% of the shares outstanding, down 4.3% from the report before. At the average daily volume of 202,577 shares, buying them all back would take about 24.8 trading days (days to cover). See the history.
Which famous investors hold DMAC?
2 of the 50 well-known investors we track reported DMAC in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $6.9M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.